의약품 물류 시장 분석 및 예측(-2035년) : 유형, 제품, 서비스, 기술, 구성 요소, 용도, 설비, 운송 수단, 단계

The global Pharmaceutical Logistics Market is projected to grow from $107.7 billion in 2025 to $244.9 billion by 2035, at a compound annual growth rate (CAGR) of 8.5%. The Pharmaceutical Logistics Market is moderately consolidated, with cold chain logistics representing the leading segment due to the growing need for temperature-controlled transportation of vaccines, biologics, and specialty medicines. The market is witnessing increased adoption of advanced technologies such as IoT-based tracking, automation, and real-time monitoring to improve supply chain visibility and regulatory compliance. The competitive landscape includes global logistics providers expanding their healthcare capabilities through investments and acquisitions. For instance, in April 2025, DHL Group announced a 2 billion investment by 2030 to enhance DHL Health Logistics capabilities, including expanding cold chain infrastructure, temperature-controlled storage, and specialized logistics solutions for biopharmaceuticals and cell and gene therapies.The market continues to evolve through strategic partnerships, digital transformation, and growing demand for reliable pharmaceutical distribution networks.

Based on Type, the Cold Chain Logistics segment dominated the Pharmaceutical Logistics Market in 2025 due to the increasing demand for temperature-controlled transportation and storage solutions for sensitive pharmaceutical products such as vaccines, biologics, and cell and gene therapies. Cold chain logistics plays a critical role in maintaining product stability, safety, and efficacy throughout the supply chain by ensuring strict temperature monitoring and regulatory compliance. Growing adoption of biologics, rising pharmaceutical exports, and increasing investments in advanced refrigeration technologies are further strengthening the demand for cold chain solutions. The expansion of global healthcare supply networks and stringent quality requirements continue to support the leadership position of cold chain logistics.

Based on Product, the Cell and Gene Therapy Products segment is projected to register the fastest growth during the forecast period, driven by increasing research activities, rising clinical trials, and growing commercialization of advanced therapies. Cell and gene therapies require highly specialized logistics solutions, including ultra-low temperature storage, real-time monitoring, and customized transportation processes to preserve product integrity. Increasing approvals of innovative therapies, expanding biotechnology pipelines, and rising investments in personalized medicine are accelerating demand for specialized pharmaceutical logistics services. The growing need for secure, traceable, and compliant transportation solutions for these complex therapies is expected to drive rapid segment expansion.

Geographical Overview

North America holds the largest share of the pharmaceutical logistics market, supported by advanced healthcare infrastructure, high pharmaceutical production, and strong demand for temperature-controlled supply chain solutions. The United States is the leading contributor, driven by a well-established pharmaceutical and biotechnology ecosystem, increasing adoption of biologics, and significant investments in healthcare logistics infrastructure. Canada also contributes through its expanding pharmaceutical manufacturing and distribution networks. The region benefits from stringent regulatory standards, advanced cold chain capabilities, and widespread adoption of digital logistics technologies, including real-time monitoring and automated warehouse solutions, which enhance supply chain efficiency and product safety.

Asia-Pacific is projected to be the fastest-growing region in the pharmaceutical logistics market, driven by expanding pharmaceutical manufacturing, rising healthcare expenditure, increasing demand for biologics, and improving healthcare infrastructure. Countries such as China and India are key growth contributors due to their large-scale pharmaceutical production capabilities, growing generic drug exports, and increasing investments in cold chain logistics networks. Japan, South Korea, and Southeast Asian countries are also witnessing increased adoption of advanced logistics solutions to support specialty medicines and clinical trial materials. Rapid urbanization, rising healthcare access, and growing pharmaceutical trade activities are expected to accelerate regional market expansion.

Key Trends and Drivers

Increasing Digital Transformation in Pharmaceutical Logistics:

The pharmaceutical logistics market is witnessing increasing digital transformation through the adoption of advanced technologies such as Internet of Things (IoT), artificial intelligence (AI), blockchain, and cloud-based platforms. These technologies are improving supply chain visibility, enabling real-time tracking of pharmaceutical shipments, and enhancing temperature monitoring for sensitive products. IoT-enabled devices help maintain required storage conditions, while AI and analytics support demand forecasting, route optimization, and inventory management. Blockchain solutions are also gaining adoption to improve traceability and reduce counterfeit risks. The growing need for transparent, efficient, and compliant pharmaceutical supply chains is accelerating the integration of digital solutions across logistics operations.

Growing Demand for Cold Chain Logistics Solutions:

The pharmaceutical logistics market is experiencing growing demand for cold chain logistics solutions due to the increasing production and distribution of temperature-sensitive products, including biologics, vaccines, and cell and gene therapies. These products require specialized storage, transportation, and monitoring systems to maintain their safety and effectiveness throughout the supply chain. Pharmaceutical companies and logistics providers are investing in advanced refrigeration technologies, temperature-controlled packaging, and real-time monitoring solutions to improve product integrity. The expansion of biologics pipelines, rising adoption of personalized medicines, and increasing global distribution of specialty drugs are expected to further drive the demand for reliable cold chain infrastructure.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by Mode
• 2.8 Key Market Highlights by Stage
• 2.9 Key Market Highlights by Equipment

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Cold Chain Logistics
  • 4.1.2 Non-Cold Chain Logistics
  • 4.1.3 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Vaccines
  • 4.2.2 Biopharmaceuticals
  • 4.2.3 Clinical Trial Materials
  • 4.2.4 OTC Drugs
  • 4.2.5 Prescription Drugs
  • 4.2.6 Blood Products
  • 4.2.7 Cell and Gene Therapy Products
  • 4.2.8 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Transportation
  • 4.3.2 Warehousing
  • 4.3.3 Packaging
  • 4.3.4 Inventory Management
  • 4.3.5 Order Fulfillment
  • 4.3.6 Customs Brokerage
  • 4.3.7 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 IoT
  • 4.4.2 Blockchain
  • 4.4.3 AI and Machine Learning
  • 4.4.4 Robotics
  • 4.4.5 Cloud Computing
  • 4.4.6 Automation
  • 4.4.7 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Software
  • 4.5.2 Hardware
  • 4.5.3 Services
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Hospital and Clinics
  • 4.6.2 Pharmaceutical Companies
  • 4.6.3 Research Institutes
  • 4.6.4 Biotechnology Companies
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Mode (2020-2035)
  • 4.7.1 Air Freight
  • 4.7.2 Sea Freight
  • 4.7.3 Road Freight
  • 4.7.4 Rail Freight
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Stage (2020-2035)
  • 4.8.1 Manufacturing
  • 4.8.2 Distribution
  • 4.8.3 Retail
  • 4.8.4 Others
• 4.9 Market Size & Forecast by Equipment (2020-2035)
  • 4.9.1 Refrigerated Containers
  • 4.9.2 Temperature Monitoring Devices
  • 4.9.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 Mode
    • 5.2.1.8 Stage
    • 5.2.1.9 Equipment
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 Mode
    • 5.2.2.8 Stage
    • 5.2.2.9 Equipment
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 Mode
    • 5.2.3.8 Stage
    • 5.2.3.9 Equipment
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 Mode
    • 5.3.1.8 Stage
    • 5.3.1.9 Equipment
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 Mode
    • 5.3.2.8 Stage
    • 5.3.2.9 Equipment
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 Mode
    • 5.3.3.8 Stage
    • 5.3.3.9 Equipment
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 Mode
    • 5.4.1.8 Stage
    • 5.4.1.9 Equipment
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 Mode
    • 5.4.2.8 Stage
    • 5.4.2.9 Equipment
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 Mode
    • 5.4.3.8 Stage
    • 5.4.3.9 Equipment
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 Mode
    • 5.4.4.8 Stage
    • 5.4.4.9 Equipment
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 Mode
    • 5.4.5.8 Stage
    • 5.4.5.9 Equipment
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 Mode
    • 5.4.6.8 Stage
    • 5.4.6.9 Equipment
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 Mode
    • 5.4.7.8 Stage
    • 5.4.7.9 Equipment
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 Mode
    • 5.5.1.8 Stage
    • 5.5.1.9 Equipment
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 Mode
    • 5.5.2.8 Stage
    • 5.5.2.9 Equipment
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 Mode
    • 5.5.3.8 Stage
    • 5.5.3.9 Equipment
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 Mode
    • 5.5.4.8 Stage
    • 5.5.4.9 Equipment
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 Mode
    • 5.5.5.8 Stage
    • 5.5.5.9 Equipment
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 Mode
    • 5.5.6.8 Stage
    • 5.5.6.9 Equipment
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 Mode
    • 5.6.1.8 Stage
    • 5.6.1.9 Equipment
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 Mode
    • 5.6.2.8 Stage
    • 5.6.2.9 Equipment
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 Mode
    • 5.6.3.8 Stage
    • 5.6.3.9 Equipment
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 Mode
    • 5.6.4.8 Stage
    • 5.6.4.9 Equipment
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 Mode
    • 5.6.5.8 Stage
    • 5.6.5.9 Equipment

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 DHL Supply Chain
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Kuehne Nagel
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 UPS Supply Chain Solutions
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 FedEx Logistics
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 DB Schenker
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 C.H. Robinson
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 XPO Logistics
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Nippon Express
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 DSV
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 GEODIS
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 CEVA Logistics
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Agility Logistics
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Panalpina
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Kerry Logistics
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Expeditors International
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Sinotrans
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Bollore Logistics
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Hellmann Worldwide Logistics
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Yusen Logistics
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Rhenus Logistics
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us